2006
DOI: 10.1111/j.1365-2885.2006.00775_5.x
|View full text |Cite
|
Sign up to set email alerts
|

WS17
Natural alternatives to antibiotic growth promoters in Europe

Abstract: Objective This Workshop offers a forum to colleagues from academia and industry. It will present a critical re‐appraisal on the rational of the EU ban, and the overall economic impact of this measure as well as regulatory attempts to stimulate licensing of new products. Additional contributions are devoted to current RD activities within the industry, and new targets and strategies in product development will be presented and discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…In addition, appropriate strategies to reduce pig and carcass cross-contamination still need to be perfected [8]. The use of antibiotics is excluded due to the intracellular persistence of this bacterium and the risk of positive selection of resistant clones [9]. In this scenario, vaccination may represent an attractive alternative for the reduction of both Salmonella incidence in swine, and the prevalence of carriers at abattoir.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, appropriate strategies to reduce pig and carcass cross-contamination still need to be perfected [8]. The use of antibiotics is excluded due to the intracellular persistence of this bacterium and the risk of positive selection of resistant clones [9]. In this scenario, vaccination may represent an attractive alternative for the reduction of both Salmonella incidence in swine, and the prevalence of carriers at abattoir.…”
Section: Introductionmentioning
confidence: 99%
“…The use of antibiotics (Abs) to control/prevent subclinical infection is not an option, given the intracellular survival of this bacterium and since many Abs are forbidden because of the potential risk of development of antimicrobial resistance (Montesissa, 2006). Vaccines against this infection in pigs are not widely used as their efficacy is, so far, questionable (Farzan and Friendship, 2009) and vaccine‐induced antibodies may cross‐react with serological tests.…”
Section: Introductionmentioning
confidence: 99%